Riastap Injection, Solution
Product Images NDC 63833-892

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Riastap (NDC 63833-892). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Csl Behring Gmbh, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (50 mL Vial Label)

This is a label of a medical product called Fibrinogen Concentrate manufactured by CSL Behring, located in Marburg, Germany. It is a US licensed product and its administration info is available on the label. It is unclear if the label contains all the necessary information as it seems to be partially incomplete and suggesting some typographical errors.*

FDA Label Image

Principal Display Panel (50 mL Vial Carton)

This is a description of a fibrinogen concentrate (human) called RiaSTARAP used for intravenous administration. It is distributed by CSL Behring GmbH and manufactured by CSL Behring LLC. The NDC code for the single-dose vial is 63833-891-51. It should be stored at temperatures between 2-8°C (36-46°F). The expiration date is indicated on the carton and vial and it can be used for up to 60 months. The package insert contains directions and information for use. It's made from human blood and may carry infectious agents like viruses, Creuzfeldt-Jakob disease (CJD) agent and theoretical substances like the OID agent.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.